Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × selinexor × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 17 Recurrence 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 5 Sarcoma 3 Neurofibrosarcoma 3 Primary Myelofibrosis 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Glioblastoma 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Vascular Neoplasms 1 Triple Negative Breast Neoplasms 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Adipose Tissue 1 Neoplasms 1 Neoplasm Metastasis 1 Myoepithelioma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1

Interventions

Cyclophosphamide 8 Biopsy 8 Specimen Handling 7 pembrolizumab 6 fludarabine 6 Whole-Body Irradiation 6 Magnetic Resonance Spectroscopy 6 Peripheral Blood Stem Cell Transplantation 5 Brentuximab Vedotin 5 fludarabine phosphate 4 duvelisib 4 Melphalan 4 10-propargyl-10-deazaaminopterin 4 ruxolitinib 3 X-Rays 3 Mycophenolic Acid 3 Immunoglobulin G 3 Gemcitabine 3 Disulfides 3 tazemetostat 2 sodium-iodide symporter 2 romidepsin 2 cemiplimab 2 belinostat 2 Sirolimus 2 Rituximab 2 Photons 2 Pharmacogenomic Variants 2 Nivolumab 2 Lenalidomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡